121 related articles for article (PubMed ID: 21043247)
1. Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity.
Cadman E; Benz C; Heimer R; O'Shaughnessy J
Biochem Pharmacol; 1981 Sep; 30(17):2469-72. PubMed ID: 21043247
[TBL] [Abstract][Full Text] [Related]
2. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.
Cadman E; Heimer R; Benz C
J Biol Chem; 1981 Feb; 256(4):1695-704. PubMed ID: 6161926
[TBL] [Abstract][Full Text] [Related]
3. Purine de novo synthesis in liver and developing rat brain, and the effect of some inhibitors of purine nucleotide interconversion.
Allsop J; Watts RW
Enzyme; 1983; 30(3):172-80. PubMed ID: 6628351
[TBL] [Abstract][Full Text] [Related]
4. The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts.
Vogt MH; Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Trijbels FJ
Biochim Biophys Acta; 1993 Apr; 1181(2):189-94. PubMed ID: 7683208
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
Lyons SD; Sant ME; Christopherson RI
J Biol Chem; 1990 Jul; 265(19):11377-81. PubMed ID: 2358467
[TBL] [Abstract][Full Text] [Related]
6. Regulation of purine synthesis de novo in human fibroblasts by purine nucleotides and phosphoribosylpyrophosphate.
Becker MA; Kim M
J Biol Chem; 1987 Oct; 262(30):14531-7. PubMed ID: 2444588
[TBL] [Abstract][Full Text] [Related]
7. Coordinate regulation of the proximal and distal steps of the pathway of purine synthesis de nono in WI-L2 human lymphoblasts.
Hershfield MS; Seegmiller JE
Adv Exp Med Biol; 1977; 76A():19-29. PubMed ID: 855704
[No Abstract] [Full Text] [Related]
8. Modulation of fluoropyrimidine metabolism in L1210 cells by L-alanosine.
Heimer R; Goldberg D; Cadman E
Biochem Pharmacol; 1983 Jan; 32(2):199-206. PubMed ID: 6870949
[TBL] [Abstract][Full Text] [Related]
9. Regulation of de novo purine biosynthesis in human lymphoblasts. Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point.
Hershfield MS; Seegmiller JE
J Biol Chem; 1976 Dec; 251(23):7348-54. PubMed ID: 1002693
[TBL] [Abstract][Full Text] [Related]
10. Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
Ardalan B; Arakawa M; Villacorte D; Jayaram H; Cooney DA
Biochem Pharmacol; 1982 Apr; 31(8):1509-13. PubMed ID: 6178415
[TBL] [Abstract][Full Text] [Related]
11. Glucagon infusion increases rate of purine synthesis de novo in rat liver.
Itakura M; Maeda N; Tsuchiya M; Yamashita K
Am J Physiol; 1987 Dec; 253(6 Pt 1):E684-90. PubMed ID: 2447786
[TBL] [Abstract][Full Text] [Related]
12. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Biochem Pharmacol; 1995 Jan; 49(1):49-56. PubMed ID: 7840782
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
Benz C; Cadman E
Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of 2-amino-6-chloro-1-deazapurine.
Bennett LL; Smithers D; Rose LM; Adamson DJ; Brockman RW
Biochem Pharmacol; 1984 Jan; 33(2):261-71. PubMed ID: 6142712
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P).
Moore EC; Hurlbert RB; Boss GR; Massia SP
Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
17. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
Natsumeda Y; Ikegami T; Olah E; Weber G
Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
[TBL] [Abstract][Full Text] [Related]
18. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
Chen ZH; Olopade OI; Savarese TM
Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
[TBL] [Abstract][Full Text] [Related]
19. Effects of metabolic inhibitors on cell lethality and mutation induction in Chinese hamster cells. I. Inhibitors of de novo purine synthesis and a comparison with the effects of caffeine.
McMillan S; Fox M
Chem Biol Interact; 1981 Jul; 36(1):71-88. PubMed ID: 7249151
[TBL] [Abstract][Full Text] [Related]
20. De novo synthesis of purine nucleotides in human blood platelets.
Jerushalmy Z; Patya M; Boer P; Sperling O
Haemostasis; 1980; 9(1):20-7. PubMed ID: 7351313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
